1Hanefcld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose:the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study. Diabetes Care 2003 ;26:868 - 874.
2Carnevale - Schianca GP, Rossi A, Sainaghi PP, et al. The significance of impaired fasting glucose versus impaired glucose tolerance:importance of insulin secretion and resistance. Diabetes Care 2003 ;26 : 1333 - 1337.
3Pratlcy RE,Wcycr C. The role of impaired early insulin secretion in the pathogenesis of type Ⅱ diabetes mellitus. Diabetologia 2001 ;44:929 - 945.
4Rodrigucz BL, Abbott RD, Fujimoto W, ct al. Thc American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese - American men. Diabetes Care 2002 ;25:951 -955.
5Balkau B,Forhan A,Eschwege E. Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose:more results from the Paris Prospective Study. Diabetologia 2002;45:1224-1230.
3Carlos E,Ferrantedo A,BenhaM W. Current developmenl in non-invasive glucose monitoring[J]. Med Eng Phys,2008,30(5):541-549.
4Himhito S,Yukio Y,Sachiko T,el al. Cross-sectional association between BMI,glycemic control and energy intake in Japanese patients with type 2 diabetes:Analysis from the Japan Diabetes Complications Sludy[J]. Diabetes Research and Clinical Practice,2007,77(5) :S23-S29.
5Maria EC,Timothy WJ,Martin S,et al. Diabetes eare,glyeemie control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region[J]. Journal of Diabetes and its Complications, 2007,21 ( 5 ) : 280-287.
8Shaul PW, Mineo C. HDL action on the vascularwall: Is the answer NO[J]. J Clin Invest, 2009,113(4):509-513.
9Braun A,Samann A,Kubiak T,etal. Effects of metabolic control,patient education and initiation of insulin therapy on the quality oflife of patients with type 2 diabetes mellitus [ J ] . Patient EducCouns,2008,73( 1):50-59.
10Mukheijee AK,Reddy VS,Shah S, et al. Quality of life as a keyindicator of patient satisfaction and treatment compliance in peoplewith type 2 diabetes mellitus in the IMPROVE study : a multicen-tre ,open label,non-randomised,observational trial [ J ] . J IndianMed Assoc,2009,107(7) :464470.
